The presence of chronic pelvic pain disease with characteristic urinary symptoms and sexual dysfunction for at least 3 months in the last 6 months, without bacterial infection of the urinary tract, is called chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). 1 Its prevalence in the population is 8.2% (2.2-9.7%). 2 The National Institutes of Health (NIH) published the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) which assesses symptoms in 3 main dimensions (pain, voiding, and quality of life) (Table 1). 2,3 The treatment of CP/CPPS may involve various medications, including alpha-blockers, tricyclic antidepressants, quercetin, antibiotics, pregabalin and sildenafil-if erectile dysfunction is present, as well as physiotherapy/pelvic floor relaxation therapies. 4 Various studies on different subgroups of CP/CPPS have not provided high-level evidence on treatment modalities, largely owing to the fact that the pathophysiology of CP/CPPS is still not fully understood. 2,4